These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 30635093)

  • 1. T Cells and Regulated Cell Death: Kill or Be Killed.
    Spetz J; Presser AG; Sarosiek KA
    Int Rev Cell Mol Biol; 2019; 342():27-71. PubMed ID: 30635093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.
    Garg AD; Agostinis P
    Immunol Rev; 2017 Nov; 280(1):126-148. PubMed ID: 29027218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cell death induced by cytotoxic lymphocytes: a dangerous but necessary liaison.
    de Miguel D; Ramirez-Labrada A; Uranga I; Hidalgo S; Santiago L; Galvez EM; Arias M; Pardo J
    FEBS J; 2022 Aug; 289(15):4398-4415. PubMed ID: 34174027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Do Cytotoxic Lymphocytes Kill Cancer Cells?
    Martínez-Lostao L; Anel A; Pardo J
    Clin Cancer Res; 2015 Nov; 21(22):5047-56. PubMed ID: 26567364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox biology of regulated cell death in cancer: A focus on necroptosis and ferroptosis.
    Florean C; Song S; Dicato M; Diederich M
    Free Radic Biol Med; 2019 Apr; 134():177-189. PubMed ID: 30639617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From cancer immunosurveillance to cancer immunotherapy.
    Stagg J; Johnstone RW; Smyth MJ
    Immunol Rev; 2007 Dec; 220():82-101. PubMed ID: 17979841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory perspective on in vitro potency assays for human T cells used in anti-tumor immunotherapy.
    de Wolf C; van de Bovenkamp M; Hoefnagel M
    Cytotherapy; 2018 May; 20(5):601-622. PubMed ID: 29598903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural compound inducers of immunogenic cell death.
    Diederich M
    Arch Pharm Res; 2019 Jul; 42(7):629-645. PubMed ID: 30955159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
    Esposito A; Criscitiello C; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity vs. cancer: predator vs. alien?
    Berens C; Lauber K; Herrmann M
    Autoimmunity; 2013 Aug; 46(5):287-93. PubMed ID: 23706137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of natural killer cell-mediated cellular cytotoxicity.
    Prager I; Watzl C
    J Leukoc Biol; 2019 Jun; 105(6):1319-1329. PubMed ID: 31107565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Interactions of Autophagy with the Immune System and Cancer.
    Jin Y; Hong Y; Park CY; Hong Y
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28771183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Witch hunt against tumor cells enhanced by dendritic cells.
    Locher C; Rusakiewicz S; Tesnière A; Ghiringhelli F; Apetoh L; Kroemer G; Zitvogel L
    Ann N Y Acad Sci; 2009 Sep; 1174():51-60. PubMed ID: 19769736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing.
    de Vries JF; von dem Borne PA; van Luxemburg-Heijs SA; Heemskerk MH; Willemze R; Falkenburg JH; Barge RM
    Haematologica; 2007 Dec; 92(12):1671-8. PubMed ID: 18055991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer.
    Ramanathan S; Gagnon J; Ilangumaran S
    Arch Immunol Ther Exp (Warsz); 2008; 56(5):311-23. PubMed ID: 18836862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell death recognition model for the immune system.
    Sun E
    Med Hypotheses; 2008; 70(3):585-96. PubMed ID: 17681705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy.
    Radogna F; Diederich M
    Biochem Pharmacol; 2018 Jul; 153():12-23. PubMed ID: 29438676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing the power of Vδ2 cells in cancer immunotherapy.
    Fowler DW; Bodman-Smith MD
    Clin Exp Immunol; 2015 Apr; 180(1):1-10. PubMed ID: 25469879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cancer stem cell: evidence for its origin as an injured autoreactive T cell.
    Grandics P
    Mol Cancer; 2006 Feb; 5():6. PubMed ID: 16478542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulation of T-cell immune exhaustion and cancer immunotherapy].
    Eikawa S; Udono H
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1066-70. PubMed ID: 25248889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.